Solagran Release: Trust in Bioeffective(R) A leads to Visit by Director of Pasteur Institute
Melbourne, Aug 21, 2007 (ACN Newswire) - Melbourne Biotech Solagran Limited (ASX: SLA) today announced that the Director of the Pasteur Institute in St Petersburg, Professor Anatoly Zhebrun DSc, has accepted the Board's invitation to visit Australia to discuss recently completed trials in relation to the use of Bioeffective(R) A in the prevention and treatment of Helicobacter Pylori infection.